Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Montelukast Oral Tablet
DRUG
3 trials
Sponsors
Bahçeşehir University
, Chinese University of Hong Kong
, Assiut University
Conditions
Allergic Rhinitis
Atherosclerosis, Coronary
COVID-19
SARS-CoV-2
Early Phase 1
Impact Of Montelukast On Allergic Rhinitis And Its Inflammatory Makers
NCT05381207
Assiut University
Allergic Rhinitis
Start: 2022-10-31
End: 2024-10-31
Target: 60
Updated: 2022-05-19
Phase 2
Investigation the Effect of Montelukast in COVID-19
NCT04718285
Bahçeşehir University
COVID-19, SARS-CoV-2
Start: 2021-05-15
End: 2022-06-01
Target: 380
Updated: 2022-04-28
Phase 4
Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China
NCT04762472
Chinese University of Hong Kong
Atherosclerosis, Coronary
Start: 2023-09-30
End: 2025-12-30
Target: 200
Updated: 2023-02-13
Related Papers
Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol.
2022-01-06
10 citations